It has been reported that the miR-106bB25 cluster, a paralog of the miR-17B92 cluster, possesses oncogenic activities. However, the precise role of each microRNA (miRNA) in the miR-106bB25 cluster is not yet known. In this study, we examined the function of miR-93, one of the microRNAs within the miR-106bB25 cluster, in angiogenesis and tumor formation. We found that miR-93 enhanced cell survival, promoted sphere formation and augmented tumor growth. Most strikingly, when miR-93-overexpressing U87 cells were co-cultured with endothelial cells, they supported endothelial cell spreading, growth, migration and tube formation. In vivo studies revealed that miR-93-expressing cells induced blood vessel formation, allowing blood vessels to extend to tumor tissues in high densities. Angiogenesis promoted by miR-93 in return facilitated cell survival, resulting in enhanced tumor growth. We further showed that integrinb8 is a target of miR-93. Higher levels of integrin-b8 are associated with cell death in tumor mass and in human glioblastoma. Silencing of integrin-b8 expression using small interfering RNA promoted cell proliferation, whereas ectopic expression of integrin-b8 decreased cell growth. These findings showed that miR-93 promotes tumor growth and angiogenesis by suppressing, at least in part, integrin-b8 expression. Our results suggest that inhibition of miR-93 function may be a feasible approach to suppress angiogenesis and tumor growth.
Introduction
MicroRNAs (miRNAs) are transcribed from a genomic DNA to generate long primary transcripts, followed by modification by RNase III-type enzymes Drosha and Dicer to produce pre-miRNAs and mature miRNAs (Lee et al., 2003 (Lee et al., , 2004 Mansfield et al., 2004; Tomari and Zamore, 2005) . A primary transcript often contains a cluster of miRNAs producing multiple pre-and mature miRNAs (Dews et al., 2006; Bonci et al., 2008) . The miR-17B92 is the most well-characterized cluster. This cluster and its paralogs, miR-106aB363 and miR-106bB25, play important roles in cancer (Ota et al., 2004; Hayashita et al., 2005; He et al., 2005; Landais et al., 2007; Petrocca et al., 2008b) because they can repress expression of many tumor-associated proteins (Sylvestre et al., 2007; Koralov et al., 2008; Mendell, 2008) . We recently analyzed mature miRNAs of the paralogs and found that some miRNAs in the three clusters are highly conserved, whereas some are very different (Shan et al., 2009 ). This suggests that some miRNAs in the clusters may perform similar functions, whereas some may function differently. It has been reported that inhibition of miR-17 and miR-20a induces apoptosis, both of which share identical seed regions and could potentially target similar mRNAs, whereas inhibition of miR-18a and miR-19a, which shares no similarity with the mature miR-17, has no effect on apoptosis, showing distinctions among miRNAs in the miR-17B92 cluster and its paralogs (Matsubara et al., 2007) . Gene knockout experiments have shown that mice lacking the miR-17B92 cluster or its paralogs exhibit reduction in B-cell numbers and formed smaller embryos. These mice developed hypoplastic lungs and have ventricular septal defects, resulting in postnatal death (Ventura et al., 2008) . On the other hand, overexpression of the miR-17B92 cluster was found to cause premature death as a consequence of lymphoproliferative diseases (Xiao et al., 2008) . We also found that overexpression of miR-17 retards tissue growth (Shan et al., 2009) . These results indicate that individual miRNAs in the same cluster can play different functions. Nevertheless, the oncogenic functions of miR-17B92, miR-106aB363 and miR-106bB25 have been reported extensively (Landais et al., 2007; Matsubara et al., 2007; Aguda et al., 2008; Fontana et al., 2008; Takakura et al., 2008; Ventura et al., 2008) . Most recently, miR-106bB25 cluster is reported to exert oncogenic effects in hepatocellular carcinoma (Li et al., 2009) . However, the precise function of each miRNA in the miR-106bB25 cluster is unclear. This cluster of miRNAs contains three pre-miRNAs, pre-miR-106b, pre-miR-93 and pre-miR-25. Interestingly, the mature miRNAs, miR-106b and miR-93, share identical seed regions, suggesting that these two miRNAs may exert prevailing functions in this cluster. This study was designed to explore the function of miR-93.
Results

miR-93 promotes tumorigenesis
Alignment of three mature miRNAs in the miR-106bB25 cluster showed that only miR-106b and miR-93 share an identical seed region (Supplementary Figure S1a) . It has been reported that this cluster and its paralogs of miRNAs play important roles in cancer development (Aguda et al., 2008; Fontana et al., 2008; Mendell, 2008; Petrocca et al., 2008a; Wang et al., 2008b; Uziel et al., 2009) . To study the role of miR-93, we generated a construct expressing miR-93 precursor ( Figure 1a ). The construct was transiently expressed in a number of cancer cell lines, including U87, C13* and OV2008. The analysis of miR-93 expression was performed by real-time PCR. The levels of miR-93 were significantly higher in all cell lines transfected with the miR-93 expression construct than the mock transfection ( Figure 1a and Supplementary Figure S1b ). Increased expression of miR-93 was also observed in C13* cell line transfected with miR-93 via Northern blotting (Supplementary Figure S1c ).
The miR-93 and mock plasmids were stably transfected in astrocytoma cell line U87. When maintained in sphere-forming medium, cells expressing miR-93 formed larger spheres than those transfected with mock (Supplementary Figure S1d) . The irregular shape of the spheres may be a consequence of cellular proliferation and aggregation. The sphere-forming cells have the characteristics of self-renewal and the potential of tumor formation (Hirschhaeuser et al., 2010) . Both groups of cells were cultured in soft agarose. The miR-93 cells formed larger colonies than the mock cells (Supplementary Figure S1e) . These results suggest that the miR-93 cells might be more tumorigenic than the mock cells.
U87 cells transfected with miR-93 or the mock control were injected subcutaneously into strain CD-1 nude mice. Tumor sizes were measured regularly. At 6 weeks after the injection, we detected much larger tumors in the mice injected with the miR-93 cells than in the control group (Figure 1b) . The mice that were killed were dissected to confirm the larger sized tumors in the miR-93 group (inset in Figure 1b ). Consistent with this was the decreased survival rate of mice bearing the miR-93 tumors compared with the controls (Figure 1c) .
The tumors were sectioned and subjected to hematoxylin and eosin staining. We found that the mock tumors contained a lot of condensed and fragmented nuclei, indicating severe cell death. In the miR-93 tumors, although some condensed nuclei could be seen, fragmented nuclei were not detected. This was particularly clear at the Â 40 magnification (Figure 2a ). At Â 20 magnification, areas containing condensed and fragmented nuclei could be seen in the mock tumors and were of larger size than in the miR-93 tumors. At low magnification ( Â 2.5), a large proportion of blue (dead) areas could only be found in the mock tumors. In the three pairs of tumors examined, all mock tumors contained condensed and fragmented nuclei. In the miR-93 tumors, however, only condensed nuclei could be found in some areas (Figure 2b) .
The in vivo data suggests that miR-93 may have prosurvival effects on tumor cells. We therefore carried out in vitro studies to test this possibility. U87 cells transfected with miR-93 or mock cells were seeded in tissue culture dishes (Figure 2c ) or Petri dishes (Supplementary Figures S2a) . The cells were maintained in serum-free conditions. Transfection with miR-93 enhanced cell survival compared with the controls. The cells were then allowed to overgrow. The mock cells exhibited severer cell death than the miR-93 cells (Supplementary Figure S2b and c) . In cell proliferation assays, we did not detect a significant difference in the growth rates in both groups of cells (Supplementary Figures S2d-f) . In an ovarian cancer cell line OV2008 stably transfected with miR-93 and mock cells, we detected increased cell survival in the miR-93-transfected cells (Supplementary Figure S3) .
To confirm the function of miR-93, we transfected U87 cells with a construct expressing an antisense against miR-93 (anti-miR-93), followed by culturing for 5 days. A significant reduction in survival rate was detected in the miR-93 cells transfected with anti-miR-93 as compared with cells expressing miR-93 alone (Figure 2d ). This excludes the possibility that the effect of miR-93 on cell survival in the stably transfected cells and in the tumor formation assays might be the consequence of gene insertion. This result also shows that endogenous miR-93 plays a role in cell survival.
miR-93 supports angiogenesis and endothelial cell activities The tumor sections were stained for CD34 expression, a marker of blood vessels. We found that the number of blood vessels in the miR-93 tumors were much higher than the number in mock tumors (Figure 3a) . The number of blood vessels was counted in 10 fields of each group with high densities of vessels, and significant difference was obtained (Figure 3b , 36.1 ± 19.9 in mock vs 96.2±28.9 in miR-93, Po0.001). Similar results were obtained when the tumor sections were probed with CD31 antibody (Supplementary Figure S4a) . The miR-93 tumor cells surrounding the blood vessels looked healthy (Figure 3c ). However, a great number of condensed, even fragmented nuclei were detected surrounding the blood vessels of the mock tumors. Furthermore, numerous blood vessels were found to be scattered in the miR-93 tumors, but in the mock tumors, miR-93 in angiogenesis L Fang et al they were restricted to layers close to the surface (Figure 3d ).
To corroborate this observation, the tumor sections were probed for CD34 expression and for cell death. In the mock tumors, extensive cell death was detected in areas close to the blood vessels, but this was not found in the miR-93 tumors (Figure 3e and Supplementary Figure S4b ). In the miR-93 tumors, some condensed nuclei could only be detected in areas far away from the blood vessels (Supplementary Figures S5a and b) . We investigated whether the miR-93 cells would affect endothelial cell activity. Both miR-93 cells and mock cells were mixed and co-cultured with the endothelial cell line Ypen, which has been extensively used in our studies and found to be a good model to study endothelial cell behavior (Zheng et al., 2004; Shan et al., 2009) . Initially, the miR-93 cells not only grew well (Supplementary Figure S6a) , but also promoted growth and expansion of the Ypen cells (Figure 4a To test the effects of miR-93 on endothelial cell activities further, we seeded U87 cells stably transfected with miR-93 or mock at different densities overnight on cell plates, followed by inoculation of endothelial cells Ypen labeled with the fluorescent dye DiI (Invitrogen, Burlington, ON, Canada) on top of the cultures. We observed that at lower cell densities, endothelial cells tended to attach to empty areas in the mock culture plates. However, endothelial cells could adhere well to the miR-93 cells (data not shown). At higher densities, endothelial cells had to stay on top of the U87 cell cultures. After overnight incubation, the endothelial cells were able to spread on top of the miR-93 cultures, but could not spread over the mock cells ( Figure 5b and Supplementary Figure S7) . A great number of miR-93 cells were able to spread on top of the Ypen cells compared with the mock cells (Figure 5c ), and we found this by counting the number of spreading cells.
Finally, the miR-93 or mock cells were mixed with the DiI-labeled Ypen cells and cultured in the Matrigel. In the presence of miR-93 cells, but not in the miR-93 culture medium alone (data not shown), Ypen cells formed more crosses (junctions of at least three tube-like structures), an indication of enhanced tube formation ( Figure 5d ). In addition, the tube structures and the complexes were larger and longer in the miR-93 treatments compared with mock ( Figure 5e ).
miR-93 represses integrin-b8 expression
Our experiments above showed that co-culturing miR-93 cells with endothelial cells supported Ypen cell spreading on top of the miR-93 cells, and stimulated Ypen cell proliferation, migration and formation of tube-like structures in the Matrigel. These results suggest that the essential miR-93 target must have exerted roles associated with these activities. Computational analysis showed that a great number of proteins associated with cell growth and tumor formation are potential targets of miR-93 (http://pictar.mdc-berlin.de/ cgi-bin/PicTar_vertebrate.cgi?action ¼ Search%20for%20 targets%20of%20a%20miRNA&amp;name2 ¼ hsa-miR-93). After extensive western blot analysis, we found that integrin-b8 appeared to be the most likely target in our study. The 3 0 -untranslated region (3 0 UTR) of integrinb8 harbors a typical target sequence for miR-93 ( Figure 6a ). It has been reported that integrin-b8 can function as a negative regulator of cell proliferation when activated by tumor growth factor-b (Cambier et al., 2000; Fjellbirkeland et al., 2003) . We analyzed integrin-b8 expression in tumor sections and cells expressing miR-93. Tumor sections were probed with anti-integrin-b8 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). In the miR-93 tumors, integrin-b8 levels were much lower than in the mock tumors (Figure 6b ). Cell lysates prepared from the miR-93 cells and mock cells were analyzed on western blot probed with anti-integrin-b8 antibody (Abcom Inc., Oakville, ON, Canada). The expression of integrin-b8 was repressed in the miR-93 cells (Figure 6c ).
Direct evidence of integrin-b8 repression was performed in U87 cells transiently transfected with mock or miR-93. Confocal microscopic examination indicated that cells transiently transfected with miR-93 had a weaker signal for integrin-b8 ( Figure 6d ) compared with the mock-transfected control cells. In addition, we transfected the miR-93 cells transiently with an antisense inhibitor against miR-93 or a control oligo, followed by performing western blot analysis in order to examine integrin-b8 expression. We found that transfecting the miR-93 inhibitor upregulated integrin-b8 expression (Figure 6e ). However, a strong upregulation was not observed, perhaps, owing to low efficiency of the inhibitor.
Computational analysis indicated that the miR-93 target site in the integrin-b8 3 0 UTR was conserved across different species (Figure 7a) . To obtain direct evidence that integrin-b8 3 0 UTR is a target of miR-93, we generated a luciferase construct harboring a fragment of the integrin-b8 3 0 UTR containing the miR-93 target sequence (Luc-Intg) and a mutant Luc-intg-mut (Figure 7b and Supplementary Figure S8a) . Luciferase activities were significantly repressed when Luc-Intg was co-transfected with miR-93 (Figure 7c ). However, mutation of the miR-93 target site abolished miR-93's effects. The effect of miR-93 on repressing luciferase activities was concentration dependent (Figure 7d ). As miR-93 shares the identical seed region with miR-17-5p, we explored the possibility that miR-17-5p can also target integrin-b8 expression by employing transgenic mice expressing miR-17-5p established by us recently (Shan et al., 2009) . Tissue lysates prepared from the heart, lung and liver of miR-17 transgenic and wild-type mice were subjected to western blot analysis and probed with anti-integrin-b8 antibody. A clear reduction in integrin-b8 expression was observed in the miR-17 transgenic organs (Supplementary Figure S8b) .
Sections obtained from the miR-93 and mock tumors were immunostained for integrin-b8 expression. Integrin-b8 signals were mostly detected in areas where nuclear condensation was found (Supplementary Figure S8c ) The tumor sections were immunostained with anti-integrin-b8 antibody. In general, tumor sections from the miR-93-transfected cells exhibited much lower levels of integrin-b8 than the control (arrows). Scale bars, 100 mm. (c) Cell lysate prepared from U87 cells transfected with miR-93 (two parallel samples) or vector was analyzed on western blot for integrin-b8 expression. Integrin expression was repressed by miR-93 transfection. (d) U87 cells transfected with miR-93 or mock were immunostained with anti-integrin-b8 antibody, followed by confocal microscopic examination. High levels of miR-93 expression (strong green fluorescent protein levels) were associated with lower levels of integrin-b8 (red, arrows). Scale bars, 20 mm. (e) U87 cells transfected with miR-93 or mock were transiently transfected with miR-93 inhibitor or a control oligo. Cell lysate prepared from these cells was run through a western blot and probed for integrin-b8 expression. Integrin-b8 expression was upregulated in the presence of miR-93 inhibitor. A band with smaller size appeared to be the degradation (Degr) fragment. Figure S8d) . Again, the levels of integrin-b8 were higher in the mock tumor sections than in the miR-93 tumor sections. To test whether or not integrin-b8 expression was correlated with miR-93 levels, a number of human cell lines were analyzed for integrin-b8 expression by western blotting (Supplementary Figure S9a) and miR-93 levels were analyzed by real-time PCR (Supplementary Figure S9b) . As U87 is a glioma cell line, we examined integrin-b8 levels in human glioblastoma samples. Tumor sections from five randomly picked patients were immunostained with anti-integrin-b8 antibody. We detected high levels of integrin-b8 expression in all tumors, especially in areas containing nuclear condensation (Figure 8a ). In the adjacent brain tissues, expression of integrin-b8 could be detected clearly. Double staining with TUNEL and CD34 indicated that the dead cells were associated with blood vessels (Figure 8b ). Integrin-b8 expression was associated with the dead areas of the tumors and could be detected clearly in the cytoplasm of brain tissue adjacent to the tumors and not in the normal area of brain tissues.
Integrin-b8 mediates miR-93 functions
To show that integrin-b8 played an essential role in mediating miR-93 function, we generated small interfering RNA (siRNA) to silence integrin-b8 expression and showed that downregulation of integrin-b8 promoted tumor cell survival. Downregulation of integrinb8 was confirmed by western blot (Supplementary Figure S9c) . Transfection of integrin-b8 siRNA greatly reduced cell death (Figure 9a ), suggesting that integrinb8-mediated pathway is essential for miR-93-enhanced cell survival.
To confirm that miR-93 promotes cell survival by targeting intergrin-b8, rescue experiments were performed. An integrin-b8 expression construct was generated and transiently expressed in the miR-93 cells. As shown in Figure 9b , reintroduction of integrin-b8 into the miR-93 cells reversed the effect of miR-93 on cell survival. Re-expression of integrin-b8 was sufficient to cause cell death, suggesting that the effect of miR-93 on enhanced survival was at least partly taking place through repression of integrin-b8 expression.
Discussion miR-93 exerts oncogenic effects miR-93 is expressed in a miRNA cluster, miR-106bB25, together with miR-106b and miR-25. Although the functions of its paralogs, miR-17B92 and miR-106aB363, have been studied extensively (Hayashita et al., 2005; Novotny et al., 2007; Aguda et al., 2008; Mendell, 2008; Ventura et al., 2008; Xiao et al., 2008; Wang et al., 2008b; Sharma et al., 2009) , the roles of miR-106bB25 are less clear. Recent studies suggest that the miR-106bB25 have oncogenic activities. The whole cluster miR-106bB25 appears to function in the development of hepatocellular carcinoma (Li et al., 2009) . One of the miRNA in the cluster, miR-93, is reported to repress the expression of ) and tumor protein 53-induced nuclear protein 1 (TP53INP1) (Yeung et al., 2008) . The extensive in vivo and in vitro experiments showed that miR-93 promoted tumor growth and tumor cell survival. Our in vivo studies showed that mice carrying miR-93-expressing tumors produced significantly larger tumors and had a lower survival rate than mice carrying control mock-expressing tumors. As the miR-93-expressing cells did not grow significantly faster than the controls, the promotion of tumor growth appeared not as a consequence of tumor cell proliferation.
Analysis of tumor sections showed signs of extensive cell death in the control group, whereas there were less signs of cell death in the miR-93 tumors. Large groups of cell complexes were seen in the mock tumors. These complexes contained condensed nuclei and fragmented nuclei. These are signs of cell death. It might be owing to the fact that these cells could proliferate in a similar miR-93 supports angiogenesis by enhancing endothelial cell activities Using in vivo and in vitro studies, we showed that miR-93 promotes angiogenesis. The miR-93 tumor sections showed much more blood vessels than the mock tumor sections. These results suggest that the miR-93 tumor cells promoted angiogenesis. Interestingly, we found that in the mock tumors, blood vessels were extensively surrounded by cells with nuclear condensation. This was unexpected, because nuclear condensation is normally an indication of cell death or pre-cell death, and angiogenesis is an indication of nutrition supplies. Our results suggest that the blood vessels in the mock tumors were not able to provide sufficient nutrition and survival factors for tumor cell growth, perhaps owing to the abnormal structures of the blood vessels. Abnormal blood vessels were detected in mouse tumor model and human brain tumors (Hagendoorn et al., 2006; Bullitt et al., 2007) . Although extensive angiogenesis may be occurring, these blood vessels may have limited capacity in facilitating tumor cell survival. Indeed, we could detect many blood vessels in the areas showing extensive cell death on/in the mock tumors, but this did not occur in the miR-93 tumors. The results of hematoxylin and eosin staining and TUNEL staining were consistent. All of them showed that the tumor cells surrounding the blood vessels underwent extensive cell death. In the miR-93 tumor sections, the morphology of tumor cells surrounding the blood vessels looked healthy and similar to those far away from the blood vessels. These results suggest that the miR-93-transfected cells not only promoted angiogenesis, but also developed a relationship with the blood vessels allowing tumor cells to survive and to grow well. The roles of miR-93 in enhancing angiogenesis were supported by a number of in vitro experiments showing that miR-93 can enhance endothelial cell activities, including cell spreading, proliferation, migration and tube formation. The endothelial cells were able to spread on top of the miR-93-transfected cells, but not on the mock-transfected cells. These results suggest that the surface of the miR-93-transfected cells were different from that of the mock-transfected cells. Perhaps, the miR-93 repressed some cell surface proteins, allowing spreading of the endothelial cells and close contact of endothelial cells to the miR-93-transfected cells. These would favor the process of blood vessel extension or angiogenesis.
In the co-culture experiments, a mixture of miR-93-transfected cells with endothelial cells greatly promoted endothelial cell proliferation. It is interesting to see that the miR-93-transfected U87 cells were, in fact, growing slower than the mock-transfected cells in the cell populations reaching sub-confluence. Although the miR-93-transfected cells grew slightly faster than the mock-transfected U87 cells that were not co-cultured with Ypen cells, the miR-93-transfected U87 cells that were co-cultured with Ypen cells produced opposite effects: they managed to grow slower making room for Ypen to expand. These results may explain at least partly the reason why miR-93 tumors contained much more blood vessels than the mock tumors, which is that miR-93-expressing cells were able to stimulate endothelial cell growth, an essential step in angiogenesis. It should be noted that there seemed to be some factors secreted by the miR-93-transfected cells or some protein fragments shed from the cell surface, which could promote endothelial cell proliferation, as the medium harvested from the miR-93-transfected cells could enhance endothelial cell growth.
Although the miR-93-transfected U87 cells did not migrate faster than the mock-transfected cells (data not shown), co-culture with the miR-93-transfected cells promoted migration of Ypen cells compared with the mock-transfected cells. Cell migration is another essential step in angiogenesis that promotes blood vessel extension. Owing to endothelial cell proliferation promoted by miR-93-transfected cells, the resulting migration could consist of a combination of endothelial cell proliferation and migration. Nevertheless, the consequence was enhanced angiogenesis promoted by miR-93 expression.
Finally, we found that tube formation was enhanced by miR-93-transfected cells when co-cultured with Ypen cells. The formation of longer and stronger tubes in the Matrigel by Ypen cells co-cultured with the miR-93-transfected cells was a strong indication of enhanced angiogenesis. When the cell number was low, no extensive tubes were formed. Larger complexes were seen in the presence of miR-93-expressing cells. This result further confirmed that the miR-93-transfected cells were able to interact well with endothelial cells facilitating blood vessel formation.
Taken together, the above results support the role of miR-93 in promoting angiogenesis. The miR-93-expressing cells could facilitate endothelial cell activities associated with blood vessel formation and extension. As a result, blood vessels were able to extend into the center of the miR-93 tumors. On the other hand, blood vessels were often detected surrounding the surface of the mock tumors. As such, these tumors could not grow big, and the tumor cells underwent extensive cell death.
miR-93 targets integrin-b8, a cell death-inducing antigen The co-culture experiments suggest that the essential miR-93 target must have exerted roles associated with these endothelial cell activities. Among them, integrin-b8 (ITGB8) appears to be the most likely candidate, which is expressed on the cell surface and can be shed to the culture medium. Integrin-b8 expression was repressed in miR-93-transfected cells, and was repressed in miR-93 tumors sections. Direct demonstration of repression of integrin-b8 expression was provided by confocal microscopic examination. Direct evidence of miR-93 targeting integrin-b8 was obtained from luciferase activity assays.
Interestingly, integrin-b8 expression was associated with nuclear condensation. Our results suggest that expression of integrin-b8 can facilitate cell death. It has been reported that integrin-b8 is a negative regulator of cell proliferation (Fjellbirkeland et al., 2003; Cambier et al., 2005) . The reduced levels of integrin-b8 on the tumor cell surface may favor endothelial cell activities and angiogenesis. Whether or not miR-93 can also regulate tumor growth factor-b expression to enhance repression of integrin-b8 awaits further investigation.
Our analysis shows that integrin-b8 expression was associated with the dead areas of the tumors and could be clearly detected in the cytoplasm of brain tissue adjacent to the tumors. The expression of integrin-b8 may be a mechanism by which the brain develops to miR-93 in angiogenesis L Fang et al inhibit tumor cell proliferation. This point may be relevant considering the growth rates of human brain tumor being much slower than that in a mouse. Our results support that integrin-b8 may function as an inhibitor of tumor growth and expansion. As the specimens were randomly picked, the consistent results suggest that the association of cell death with the expression of integrin-b8 and CD34 may be of general significance clinically. The extensive staining of the endothelial cells in the reoccurred brain tumor after radiotherapy (sample BT1320) is consistent with our in vitro results of wound healing experiments, in which we found that the endothelial had great capacity in expanding into the wounded areas. Two lines of evidence support the role of integrin-b8 in mediating miR-93 function. First, downregulation of integrin-b8 expression with siRNA promoted tumor cell survival. This correlates with the role of miR-93 in cell survival. Second, overexpression of integrin-b8 reversed the effect of miR-93 on cell survival. Thus, the role of miR-93 on cell survival is mediated, at least in part, by downregulation of integrin-b8. It is conceivable that miR-93 also targets some other mRNAs in the cell, as miR-93 potentially targets a great number of genes.
In summary, we have shown that miR-93 functions as an oncogene by enhancing tumor cell survival, blood vessel expansion and tumor growth, and that it exerts these effects by targeting, at least in part, integrin-b8 expression. miR-93 can potentially target a great number of genes. Some of them directly act on tumorigenesis and angiogenesis. Some of them may affect other proteins and indirectly affect tumorigenesis and angiogenesis. Thus, we cannot exclude the possibility that other miR-93 targeting proteins are also important in the system. Future investigation would involve dissecting the network by which miR-93 functions.
Materials and methods
Construct generation
A cDNA sequence containing two human pre-miR-93 units was inserted into a mammalian expression vector pEGFP-N1 in the restriction enzyme sites BglII and HindIII (Figure 1c) . The sequence of pre-miR-93 is the same as the endogenous sequence. Cells transfected with the miR-93 construct also exhibited green fluorescence.
Two primers Huint-b8-SacI (5 0 -GGGGAGCTCTAAAAA AAGATTTTTAAACACTTAATGG-3 0 ) and Huint-b8-MluI (5 0 -CCCACGCGTGTTATATATTACAGTAAAGTGCTAC-3 0 ) were used to clone a fragment of the integrin-b8 3 0 UTR by reverse transcription-PCR. The PCR product was digested with SacI and MluI, followed by insertion into a SacI-and MluI-digested pMir-Report vector. To generate a mutant containing a mutation in the miR-93 target site, a primer Huint-b8-MluI-mut (5 0 -CCCACGCGTGTTATATATTACA GTATTCACGTACAAC-3 0 ) was combined with the primer Huint-b8-SacI in a PCR. The PCR product was digested with SacI and MluI and inserted into a SacI-and MluI-digested pMir-Report vector.
The integrin-b8 cDNA containing the coding sequence was purchased from American Type Culture Collection (ATCC, Rockville, MD, USA). The coding sequence was amplified by PCR and the PCR product was cloned into pCR3.1 vector (Invitrogen). The identity of the insert was confirmed by DNA sequencing.
Real-time PCR Total RNAs were extracted from cell cultures with mirVana miRNA Isolation Kit (Ambion, Streetsville, ON, Canada) according to the manufacturer's instructions. Reverse transcription-PCRs were performed as described previously (Lee et al., 2007) . For mature miRNA analysis, the total RNAs were extracted from B1 Â 10 6 cells, followed by first-strand cDNA synthesis using 1 mg RNA. In the following steps, PCRs were performed with QuantiMir-RT Kit using 1 ml cDNA as template. To perform these experiments, other kits were also needed, including Qiagen (Mississauga, ON, Canada), miScript Reverse Transcription Kit, cat. no. 218060, miScript Primer Assay, cat. no. 218411, and miScriptSYBR Green PCR Kit, cat. no. 218073. The primer specific for mature miR-93 was purchased from Qiagen. The primers used as real-time PCR controls were human-U6RNAf and human-U6RNAr as described (Shan et al., 2009) .
Western blotting
Cell lysates were prepared from cells seeded on six-well plates at 10 6 cells per well by lysing the cells in each well with 100 ml lysis buffer containing protease inhibitors. Protein concentrations were measured by Bio-Rad protein assay kit. Lysates containing 30-80 mg protein were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The separated proteins were transferred to a nitrocellulose membrane followed by immunostaining with a primary antibody overnight at 4 1C. Next day, the membrane was washed and incubated with horse radish peroxidase-conjugated goat-antimouse secondary antibody for 2 h at room temperature followed by ECL detection. After detection of protein bands, the blot was re-probed with anti-b-actin antibody to confirm equal loading of samples.
Luciferase activity assays U343 cells were cultured on 24-well tissue culture plates at a density of 3 Â 10 4 cells per well in Dulbecco's modified Eagles's medium (DMEM) containing 10% fetal bovine serum (FBS). The cultures were maintained at 37 1C for 24 h, followed by co-transfection with the luciferase reporter constructs and miRNAs (from GenePharma, Shanghai, China) using Lipofectamine 2000 following the methods described by us recently (Lee et al., 2007; Wang et al., 2008a) . The cells were then collected and lysed with a luciferase-specific lysis buffer from Luciferase Assay Kit (Promega, Nepean, ON, Canada). The mixture of cell lysates was centrifuged at 3000 r.p.m. for 5 min. The supernatants were transferred into a black 96-well plate (3 Â 10 ml) for luciferase activity measurement and into a transparent 96-well plate (3 Â 50 ml) for b-gal activity analysis. For the luciferase activity measurement, luciferase assay reagent (70 ml) was added to each well and the luciferase activities were detected by using microplate scintillation and luminescence counter (Packard, Perkin Elmer, Woodbridge, ON, Canada). For the internal control of b-gal activities, 90 ml of assay reagent (4 mg/ml ortho-nitrophenyl-b-galactoside, 0.5 M MgSO 4 , b-mercaptoethanol and 0.4 M sodium phosphate buffer) were added to each well. The plate was then incubated at 37 1C for 60 min. The absorbance at 410 nm was measured by using a microplate reader (Bio-Tek Instruments Inc., Winooski, VT, USA). All experiments were repeated three times.
miR-93 in angiogenesis L Fang et al
Cell survival assay Cells (1.5 Â 10 5 or 2 Â 10 5 cells per well) were seeded on 35-mm Petri dishes or 12-well tissue culture dishes in DMEM containing 0-10% FBS, and incubated for different time periods. The cell numbers were counted by using trypan blue staining as described (Wang et al., 2008a; Lee et al., 2009) . The experiments were repeated three times.
Colony formation in soft agarose gel Colony formation was assessed using a method described previously (Zheng et al., 2004) . In brief, 10 3 cells were mixed in 0.3% low-melting agarose (Seaplaque, FMC) in DMEM supplemented with 10% FBS and plated on 0.66% agarosecoated six-well tissue culture plates, preventing attachment of cells to the plates. The culture medium was changed twice a week with 0.5 ml DMEM containing 10% FBS. At 4 weeks after cell inoculation, colonies were examined and photographed under a light microscope.
Co-culture experiments
In Ypen cell spreading experiments, the miR-93 cells or mock cells were cultured at different cell densities (0.5-1.5 Â 10 5 cells per well) overnight. Next day, Ypen cells were inoculated on top of the U87 cell cultures (6 Â 10 4 cells per well). Ypen cell spreading on top of the U87 cells was examined with light and fluorescent microscopy.
In Ypen cell proliferation assays, the miR-93 cells or mock cells were co-cultured with Ypen cells (1.5 Â 10 5 cells per ml for each), followed by examination of cell growth under a light microscope. As well, culture medium collected from the miR-93-or mock-transfected U87 cells, after 1 day culture at 1.5 Â 10 5 cells per well in six-well plates, was used to culture Ypen cells (6 Â 10 4 cells per well). Cell number was counted on different days to estimate the effect of the spent medium on Ypen proliferation.
Wound healing experiments were performed to examine cell migration. The mock cells or miR-93 cells were mixed with Ypen cells (1.5 Â 10 5 cells per ml for each) and seeded on 3.5-cm culture dishes in DMEM supplemented with 10% FBS (2 ml). At 24 h after cell inoculation, sub-confluent monolayers were wounded linearly by scraping with p1000 pipette tips, washed to remove cell debris and refilled with fresh media. The images were captured at the beginning and at different intervals later with a phase-contrast microscope.
To test the effect of miR-93 on tube formation of Ypen cells, we mixed the miR-93 cells or mock cells with Ypen cells. The mixture was cultured in the Matrigel. The interaction of both types of cells and the formation of tube structures were examined with light and fluorescent microscopy.
Tumorigenicity assays in nude mice
Five-week-old CD1 strain nude mice were injected subcutaneously with miR-93-or mock-transfected U87 cells (5 Â 10 6 cells per mouse) using the methods described previously (Zheng et al., 2004) . When lesions were detected or the sizes of the tumors reached the limited size set by Sunnybrook Animal Committee, the mice were killed for tumor harvest. The tumor sections were subjected to hematoxylin and eosin staining, immunostaining for CD34 expression and TUNEL staining. Sections were also immunostained for integrin-b8 expression. The tumor formation assays were repeated three times.
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